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ABSTRACT The aim of the present study was to gain
insight into the signaling pathway used by leptin to stim-
ulate lipolysis. The lipolytic rate of white adipocytes from
sex- and age-matched lean (1/1) and fa/fa rats was
determined in the absence or presence of leptin together
with a number of agents acting at different levels of the
signaling cascade. Leptin did not modify FSK-, dbcAMP-,
and IBMX-stimulated lipolysis. Lipolysis can also be max-
imally stimulated by lowering media adenosine levels with
adenosine deaminase (ADA), i.e., in the ligand-free state.
Although ADA produced near maximal lipolysis in adipo-
cytes of lean animals, only half of the maximal lipolytic
rate (50.963.2%) was achieved in fat cells from fa/fa rats
(P50.0034). In adipocytes from lean animals preincu-
bated with ADA, leptin caused a concentration-related
stimulation of lipolysis (P50.0001). However, leptin had
no effect on the lipolytic activity of adipocytes in the
ligand-free state from fa/fa rats. The adenosine A1 recep-
tor agonist CPA effectively inhibited basal lipolysis in both
lean and obese adipocytes (P50.0001 and P50.0090,
respectively). Leptin had no effect on the lipolytic rate of
adipocytes isolated from fa/fa rats and preincubated with
CPA. When adipocytes were incubated with the A1 recep-
tor antagonist DPCPX, a significant increase in glycerol
release was observed in fa/fa fat cells (P50.009), whereas
cells isolated from lean rats showed no differences to
ADA-stimulated lipolysis. After pretreatment with PTX,
which inactivates receptor-mediated Gi function, adipo-
cytes of obese rats became as responsive to the stimula-
tory actions of ISO as cells from lean rats (P50.0090 vs.
ISO in fa/fa rats; P50.2416 vs. lean rats, respectively).
PTX treatment of lean cells, however, did not alter their
response to this lipolytic agent. It can be concluded that
the lipolytic effect of leptin is located at the adenylate
cyclase/Gi proteins level and that leptin-induced lipolysis
opposes the tonic inhibition of endogenous adenosine in
white adipocytes.—Fru¨hbeck, G., Go´mez-Ambrosi, J., Sal-
vador, J. Leptin-induced lipolysis opposes the tonic inhi-
bition of endogenous adenosine in white adipocytes.
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Unraveling the diverse hormonal and neuroendo-
crine systems that regulate energy balance and body fat
has been a long-standing challenge in biology, with
obesity an increasingly important public health focus. A
major development in energy balance regulation came
with the discovery in 1994 of leptin, the protein prod-
uct of the ob gene (1). The initial concept was that
leptin informs the brain about the abundance of body
fat, thereby allowing feeding behavior, metabolism, and
endocrine physiology to be coupled to the nutritional
state of the organism (2). The original view, however,
has evolved considerably over recent years with the
finding of the extreme functional pleiotropy of leptin
and its involvement in such diverse physiological func-
tions as reproduction (3), hematopoiesis (4), angiogen-
esis (5), immune responsiveness (6), and blood pres-
sure control (7).
Adenoviral transfer of the leptin gene into rats has
been shown to dramatically reduce tissue triglyceride
stores compared with pair-fed controls, providing evi-
dence for a role for leptin beyond its appetite-reducing
properties (8, 9). Despite equivalent reductions in food
intake and weight gain in hyperleptinemic rats by
adenoviral transfer of the leptin gene and pair-fed
animals, identifiable fat tissue was completely ablated
only in the former group. Fat could not be identified in
either subcutaneous, visceral, retroperitoneal, or epi-
didymal fat depots of hyperleptinemic adenovirally
transferred rats. In pair-fed animals, fat depots were
preserved in all sites, although below normal control
levels (8). The lipopenic action of hyperleptinemia on
adipocytes has been reported not to be mediated by
neurotransmitted signals from the central nervous sys-
tem (10). The same group has demonstrated a novel
form of lipolysis by which the leptin-induced glycerol
release is not accompanied by a rise in plasma free fatty
acids (11). Previous studies have also shown an auto-
crine-paracrine lipolytic effect of leptin on white adi-
pose tissue both in vitro and in vivo (12–14). However,
the mechanisms of leptin-induced lipolysis still remain
to be completely elucidated.
Lipolysis is controlled by intracellular cAMP, whose
concentrations in fat cells are influenced by activation
of receptors interacting with adenylate cyclase. Acting
through the A1 receptor on the adipocyte plasma
membrane coupled to the inhibitory guanosine 59-
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triphosphate (GTP) binding proteins Gi, adenosine is
implicated in the regulation of adenylate cyclase and,
therefore, in lipolysis control (15, 16). Endogenously
released adenosine provides a tonic inhibition of lipol-
ysis in isolated adipocytes. Addition of adenosine
deaminase (ADA) to fat cell incubations results in the
‘ligand-free’ state described by Honnor et al. (15), i.e.,
when tonic inhibition by adenosine is removed in
adipocytes from fasted animals and maximal rates of
lipolysis can be achieved. Activation of the sympathetic
nervous system also contributes to the control of adi-
pose tissue metabolism. The modulatory effects of
catecholamines on fat cell function involve various
adrenoreceptor subtypes connected with different
transducing systems (17). Fat mobilization is mediated
mainly by b-adrenergic agonists and lipolysis stimula-
tion.
The regulatory nature of lipolysis in fat cells permits
the pharmacological dissection of the site of action of
lipolytic agents. The aim of the present study, there-
fore, was to gain further insight into the signaling
pathway used by leptin to stimulate lipolysis. Agents
acting at the b-adrenoreceptor, adenylate cyclase, A1
adenosine receptor, phosphodiesterase, and protein
kinase A levels were assayed in vitro on fat cells from
control rats in the presence or absence of leptin. The
same combinations of lipolytic agents were further
studied in adipocytes isolated from sex- and age-
matched obese Zucker (fa/fa) rats to examine the effect
of defective leptin receptors on the stimulation of
lipolysis.
MATERIALS AND METHODS
Animals
Experiments were performed in 3-month-old male lean
(1/1) and obese Zucker (fa/fa) rats (Harlan, Oxon, U.K.).
All experimental procedures conformed to the National
Institute of Health Guide for the Care and Use of Laboratory
Animals.
Adipocyte isolation and lipolysis measurements
Isolation of adipocytes from lean and obese rats was per-
formed following the method of Rodbell (18) as modified by
Galitzky et al. (19) and as described earlier (13, 14). Briefly,
minced abdominal fat depots were digested at 37°C for 90
min with collagenase P in Krebs-Ringer bicarbonate buffer
containing albumin (3.5 g/100 ml) and glucose (6 mM) at
pH 7.4 (KRBA). The ratio of digestion solution to adipose
tissue mass was 5 ml/g and 0.75 ml of KRBA/mg of collage-
nase. The fat samples were incubated in 50 ml polypropylene
vials under continuous vigorous shaking (90 cycles/min).
After the digestion period, cell suspension was filtered
through nylon mesh and washed three times with KRBA to
eliminate the stromavascular fraction and collagenase. The
disaggregated fat cells were brought to a suitable dilution in
KRBA buffer. Adipocytes were incubated in polyethylene
tubes with continuous gentle shaking (30 cycles/min) in a
water bath at 37°C. Lipolysis was determined in the absence
or presence of leptin (0.63, 6.25, and 62.5 nM) together with
a number of agents acting at different levels of the signaling
cascade: 1) at the b-adrenoreceptor [isoproterenol (ISO, 1
mM)]; 2) at the adenylate cyclase [forskolin (FSK 10 mM) and
adenosine deaminase (ADA 10 mg/ml)]; 3) at the A1 adeno-
sine receptor [N6-cyclopentyladenosine (CPA, 10 mM) and
8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 1 mM)]; 4) at the
phosphodiesterase [isobutylmethylxanthine (IBMX, 0.1
mM)]; 5) at the protein kinase A [dibutyryl-cyclic AMP
(dbcAMP, 1 mM)]. After 90 min, the incubation tubes were
placed in an ice bath and 200 ml of the infranatant was
removed for enzymatic determination of glycerol released
into the incubation medium, which was taken as the index of
lipolytic rate (20). Total lipid content was evaluated gravimet-
rically after extraction as described by Dole and Meinertz
(21). The maximal lipolytic response was achieved in adipo-
cytes isolated from both lean and obese rats by incubation
with IBMX 0.1 mM. This IBMX-stimulated lipolysis value
obtained in (1/1) and (fa/fa) fat cells was used as 100% of
stimulation for the lean and obese groups, respectively.
Treatment of isolated adipocytes with pertussis toxin
Adipocytes were prepared as described above but were resus-
pended in KRBA containing 5% albumin and 200 nM aden-
osine. Pertussis toxin (PTX) was added to a final concentra-
tion of 350 ng/ml, and the cells were maintained with gentle
stirring at 37°C. At 30 min intervals, fat cells were resus-
pended in fresh buffer. Effectiveness of the PTX treatment
was assessed by the loss of receptor-mediated CPA inhibition
of FSK-stimulated activity. Adipocytes isolated from lean rats
required 2 h for effective PTX treatment, whereas 90 min was
sufficient to abolish receptor-mediated Gi activity in fat cells
obtained from fa/fa animals. At the end of the incubation
period, adipocytes were washed free of PTX and incubated
under the experimental conditions described.
Drugs
Recombinant murine leptin was purchased from PeproTech
EC Ltd. (London, U.K.). The OB protein showed more than
95% purity as evidenced by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis and high-performance liquid chro-
matography analyses. Leptin was dissolved in phosphate-
buffered saline at pH 7.4. Bovine serum albumin (fraction V),
FSK, dbcAMP, IBMX, ISO bitartrate salt, and PTX were
obtained from Sigma Chemical Co. (St. Louis, Mo.). CPA and
DPCPX were purchased from ICN Biomedicals Ltd. (Oxford-
shire, U.K.). Collagenase P (from Clostridium histolyticum,
activity 1.52 U/mg), ADA, glycerol-3-phosphate dehydroge-
nase, and glycerol kinase were obtained from Boehringer
Mannheim GmbH (Mannheim, Germany). All drugs were
made fresh on the day of the experiment.
Data analyses
Results are presented as means 6 se of separate experiments
performed in duplicate. Intergroup differences were com-
puted by one-way analysis of variance (ANOVA), followed by
Scheffe’s F test for post hoc pairwise comparisons. Dose-
dependency was tested by a factorial ANOVA using linear
trend testing. Changes from baseline were studied by Stu-
dent’s two-tailed, paired t test. Within the lean group the
effect of the lipolytic agents in the different pharmacological
settings was analyzed by Student’s two-tailed, unpaired t tests.
The nonparametric Kruskal-Wallis test, followed by U Mann-
Whitney’s pairwise comparisons was applied due to the small
number of animals used in the lipolytic experiments carried
out on fa/fa rats. Responses to the same pharmacological
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treatment in adipocytes obtained from lean and obese rats
were compared by U Mann-Whitney’s tests. Analyses were
performed using the StatView 4.01 Non-FPU (Abacus Con-
cepts, Inc. ©1992–93, Berkeley, Calif.) statistical package for
Apple Macintosh computers. Differences were considered
statistically significant at the P ,0.05 level.
RESULTS
Effect of leptin on basal and maximally stimulated
lipolysis
In adipocytes obtained from lean rats the three leptin
concentrations tested (0.63, 6.25, and 62.5 nM) pro-
duced a statistically significant increase in the basal
lipolytic rate (F534.65; P50.0001; saline control:
0.571 6 0.015 mmol glycerol/100 mg lipids; Fig. 1).
The highest dose of leptin produced a 57.5 6 7.3%
increase in glycerol release compared to the basal
lipolytic rate (P,0.001). The lowest dose of leptin
produced a more modest increase in the glycerol
released to the incubation medium (21.560.8%),
which was also significantly different from the saline
control (P,0.05). The effect of leptin on lipolysis was
significantly dose dependent on linear trend testing
(P50.0001).
To study the influence of leptin on different steps of
the signal transduction pathway, the effect of the OB
protein on ISO-, FSK-, IBMX-, and dbcAMP-stimulated
lipolysis was analyzed. None of the three leptin concen-
trations tested modified the maximal lipolytic stimula-
tion elicited by ISO, FSK, and dbcAMP in fat cells of
lean animals (Fig. 1). Although a marked decrease in
the release of glycerol was observed in IBMX-treated
adipocytes after exposure to leptin, it did not reach
statistical significance (P50.09).
As expected, addition of leptin to the incubation
medium did not alter the lipolytic rate of white adipo-
cytes obtained from fa/fa rats, the mutant rodents that
lack functional leptin receptors. However, incubation
of fat cells of obese Zucker animals with ISO, FSK,
IBMX, and dbcAMP produced a marked lipolytic re-
sponse (P,0.001), thus showing that the adipocyte
preparations from these rats are not defective to other
known lipolytic agents (Fig. 2). In these adipocytes,
addition of leptin had no effect on ISO-, FSK-, IBMX-,
and dbcAMP-stimulated lipolysis either.
Basal lipolysis in the absence of adenosine
Lipolysis in isolated adipocytes can be maximally stim-
ulated in the absence of added b-agonists by lowering
media adenosine levels with ADA. Although ADA pro-
duced near maximal lipolysis in adipocytes of lean
animals (Fig. 3), only half of the maximal lipolytic rate
(50.963.2%) was achieved in fat cells from fa/fa rats
(P50.0034). In adipocytes from lean animals preincu-
bated with ADA, leptin caused a concentration-related
Figure 1. Effect of leptin on basal (control) and stimulated
lipolysis in adipocytes of lean rats. The lipolytic rate was
measured as the amount of glycerol released after 90 min of
incubation with three doses of leptin and treatment with
isoproterenol (ISO 1 mM), forskolin (FSK 10 mM), isobutyl-
methylxanthine (IBMX 0.1 mM), and dibutyryl-cyclic AMP
(dbcAMP 1 mM). Data are normalized to basal lipolysis of fat
cells from saline-treated animals (saline control: 0.571 6
0.015 mmol glycerol/100 mg lipids) and are means 6 se (n58
per group; lipolytic experiments were performed in dupli-
cate). Statistical comparisons were made by ANOVA, followed
by Scheffe’s post hoc pairwise comparisons; *P,0.05,
***P,0.001 vs. saline; #P,0.05, ###P,0.001 vs. 0.63 nM
leptin; §P,0.05 vs. 6.25 nM leptin.
Figure 2. Effect of leptin on basal (control) and stimulated
lipolysis in adipocytes of fa/fa rats. The lipolytic rate was
measured as the amount of glycerol released after 90 min of
incubation with three doses of leptin and treatment with
isoproterenol (ISO 1 mM), forskolin (FSK 10 mM), isobutyl-
methylxanthine (IBMX 0.1 mM), and dibutyryl-cyclic AMP
(dbcAMP 1 mM). Data are normalized to basal lipolysis of fat
cells from saline-treated obese animals (saline control:
0.443 6 0.062 mmol glycerol/100 mg lipids) and are means 6
se (n55 per group; lipolytic experiments were performed in
duplicate). Statistical comparisons were made by the Kruskal-
Wallis test.
335LEPTIN BLUNTS TONIC ADENOSINE LIPOLYSIS INHIBITION
stimulation of lipolysis (P50.0001). Addition of the
three leptin concentrations (0.63, 6.25, and 62.5 nM)
in the ligand-free state (44.0610.3%, 64.467.5%, and
94.6613.4% of the saline control, respectively) com-
pared to the basal control condition (21.560.8%,
39.863.1%, and 57.567.3% of the saline control, re-
spectively) produced a statistically significant increase
in the stimulation of lipolysis (P50.048; P50.009, and
P50.029, respectively) of fat cells obtained from lean
animals. On the contrary, leptin had no effect on the
lipolytic activity of adipocytes in the ligand-free state
from fa/fa rats (Fig. 4).
Effect of A1 agonism on lipolysis
The adenosine A1 receptor agonist CPA effectively inhib-
ited basal lipolysis in both lean and obese adipocytes
(P50.0001 and P50.0090, respectively). Addition of the
higher concentrations of leptin to fat cells from lean
animals pretreated with CPA was followed by a statistically
significant (P,0.01) stimulation of lipolysis compared to
the basal adenosine A1 receptor agonism state. The lowest
dose of leptin tested produced a more modest increase in
glycerol release that was not significantly different from
the saline control. Addition of the three leptin concentra-
tions to adipocytes under A1 receptor agonism of lean rats
(12.561.3%, 15.260.7%, and 18.260.9% of maximal
lipolysis, respectively) compared to the control conditions
(17.660.2%, 20.260.4%, and 22.861.1% of maximal
lipolysis, respectively) yielded consistently lower rates of
lipolysis (P,0.006). In the presence of CPA, adipocytes
isolated from lean rats exhibited a statistically lower lipo-
lytic activity than fat cells obtained from fa/fa animals
(10.260.7% vs. 13.460.5% of maximal lipolysis, respec-
tively; P50.0084). Leptin had no effect on the lipolytic
rate of adipocytes isolated from fa/fa rats and preincu-
bated with CPA.
Effect of A1 antagonism on lipolysis
To further characterize the influence of the A1 adeno-
sine receptor in lipolysis, the effect of the A1 receptor
antagonist DPCPX was studied. When adipocytes were
incubated with DPCPX, a statistically significant in-
crease in glycerol release was observed in fa/fa fat cells
(P50.009) whereas cells isolated from lean rats showed
no differences to ADA-stimulated lipolysis (P50.3811).
Only addition of the higher concentrations of leptin to
the incubation medium of fat cells under A1 receptor
antagonism from lean rats was followed by a statistically
significant (P,0.01) stimulation of lipolysis. As before,
leptin had no effect on the lipolytic activity of adipo-
cytes isolated from fa/fa rats and pretreated with
DPCPX (Fig. 4).
Figure 4. Effect of leptin on basal (control) and stimulated
lipolysis in adipocytes of fa/fa rats. The lipolytic rate was
measured as the amount of glycerol released after 90 min of
incubation with three doses of leptin and treatment with
adenosine deaminase (ADA 10 mg/ml), the A1 adenosine
receptor agonist N6-cyclopentyladenosine (CPA 10 mM), and
the A1 adenosine receptor antagonist dibutyryl-cyclic AMP
(dbcAMP 1 mM). Results are expressed as the percent of
maximally stimulated lipolysis of fat cells from obese animals
(maximum: 1.91660.090 mmol glycerol/100 mg lipids) and
are means 6 se (n55 per group; lipolytic experiments were
performed in duplicate). Statistical comparisons were made
by the Kruskal-Wallis test.
Figure 3. Effect of leptin on basal (control) and stimulated
lipolysis in adipocytes of lean rats. The lipolytic rate was
measured as the amount of glycerol released after 90 min of
incubation with three doses of leptin and treatment with
adenosine deaminase (ADA 10 mg/ml), the A1 adenosine
receptor agonist N6-cyclopentyladenosine (CPA 10 mM), and
the A1 adenosine receptor antagonist dibutyryl-cyclic AMP
(dbcAMP 1 mM). Results are expressed as the percent of
maximally stimulated lipolysis of fat cells from lean animals
(maximum: 3.944 6 0.072 mmol glycerol/100 mg lipids) and
are means 6 se (n58 per group; lipolytic experiments were
performed in duplicate). Statistical comparisons were made
by ANOVA, followed by Scheffe’s post hoc pairwise compari-
sons; *P,0.05, **P,0.01, ***P,0.001 vs. saline.
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Pertussis toxin treatment of adipocytes
The possibility that receptor Gi-mediated inhibition of
adenylate cyclase might cause the reduced sensitivity to
lipolytic hormones observed in fa/fa fat cells was tested
by treating the cells with PTX. After pretreatment with
the toxin, adipocytes of obese rats became as responsive
to the stimulatory actions of ISO as cells from lean rats
(P50.0090 vs. ISO in fa/fa rats; P50.2416 vs. lean rats,
respectively). PTX treatment of lean cells, however, did
not alter their response to this lipolytic agent
(P50.5059) (Fig. 5).
Pertussis toxin effectively inactivated receptor-medi-
ated Gi function as demonstrated by the inability of
CPA to inhibit FSK-stimulated lipolysis in the treated
adipocytes. Addition of leptin to the incubation me-
dium of lean adipocytes under these experimental
conditions resulted in a dose-dependent increase in the
lipolytic rate (Fig. 6). Whereas leptin did not modify
FSK-stimulated lipolysis under physiological circum-
stances, after PTX treatment leptin produced a statisti-
cally significant (P50.0001) increase in glycerol release
of lean adipocytes. As before, incubating fat cells ob-
tained from fa/fa rats with leptin, even under the
pharmacological setting of inactivating the inhibitory
arm of the pathway by PTX pretreatment, had no
significant effect on lipolysis compared to the saline
control (Fig. 6).
DISCUSSION
Although leptin-induced lipolysis has been described
(11–14), the underlying mechanisms still remain to be
elucidated. The lipolytic effect clearly needs function-
ally competent leptin receptors since it could not be
replicated in adipocytes of obese Zucker rats, which are
known to harbor a partially inactivating mutation in the
leptin receptor gene. In the present study, the lack of
effect of leptin on ISO-induced lipolysis in the in vitro
assays suggests that leptin does not interfere with
catecholamine-mediated lipolysis through interaction
with the b-adrenergic receptors. Furthermore, the lack
of effect of leptin on dbcAMP-mediated lipolysis sug-
gests that the hormone does not interfere at the
protein kinase A level either. Although a marked
decrease in the release of glycerol was observed in
IBMX-treated adipocytes after exposure to leptin, it did
not reach statistical significance. However, the possibil-
ity that leptin may interfere at the phosphodiesterase
level should not be ruled out completely. This assertion
is also based on previous studies reporting a short-term
inhibition of insulin secretion by leptin through a
phosphodiesterase-dependent effect on cAMP concen-
trations (22, 23).
The dual regulatory nature of the adenylate cyclase
system in the adipocyte allows us to pharmacologically
dissect the site of action of lipolytic agents. The A1
adenosine receptor is a typical transmembrane, Gi
Figure 5. Comparison of the effect of pertussis toxin (PTX)
treatment on isoproterenol (ISO 1 mM)-stimulated lipolysis of
adipocytes isolated from lean and obese rats. As in Figs. 3 and
4, data are normalized to maximally stimulated lipolysis of fat
cells from lean and obese groups, respectively, and are
means 6 se (n58 per group in lean rats; n55 per group in
fa/fa rats; lipolytic experiments were performed in duplicate).
Statistical comparisons were made by U Mann-Whitney’s test;
***P,0.001 vs. the same drug group of lean rats; ###P,0.001
vs. no PTX treatment within the obese group.
Figure 6. Comparative effects of pertussis toxin (PTX) treat-
ment on the addition of leptin to forskolin-stimulated lipoly-
sis of adipocytes obtained from lean and fa/fa rats. Forskolin-
stimulated lipolysis was taken as 100%. Effectiveness of PTX
treatment was assessed by the loss of receptor-mediated
N6-cyclopentyladenosine (CPA 10 mM) inhibition of forsko-
lin-stimulated activity. Statistical comparisons were made by
ANOVA, followed by Scheffe’s post hoc pairwise comparisons
in the lean rats. In obese Zucker rats, statistical comparisons
were made by the Kruskal-Wallis test, followed by U Mann-
Whitney’s tests for pairwise comparisons; ***P,0.001 vs.
saline not pretreated with PTX; #P,0.05, ##P,0.01,
###P,0.001 vs. saline group pretreated with PTX.
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protein-linked receptor widely distributed in adipose
tissue and best known for its capacity to inhibit adenylyl
cyclase (24). To gain insight into the likely mechanisms
implicated, lipolysis was stimulated by addition of ADA,
which degrades the adenosine that is endogenously
released by isolated adipocyte preparations. Although
ADA produced nearly maximal lipolysis in lean fat cells,
in adipocytes obtained from fa/fa rats only half of the
maximal rate of lipolysis was achieved. Addition of the
A1 adenosine receptor agonist CPA effectively inhibited
basal lipolysis in both lean and obese adipocytes. To
further validate the underlying assumption that leptin
is involved in the modulation of lipolysis at the ad-
enosinergic level, the effect on glycerol release of the
adenosine A1 receptor antagonist DPCPX was studied.
When the influence of A1 receptors on lipolysis is
blocked by DPCPX, the stimulatory effect on the lipo-
lytic rate clearly outweighs the absent tonic influences,
leading to near maximal lipolysis stimulation. In our
study a wide range of leptin concentrations encompass-
ing the physiological values were tested. It is noteworthy
that leptin at concentrations as low as 0.1 nM has been
shown to stimulate basal lipolysis in white fat pads ex
vivo in a time- and dose-dependent manner (12). The
fact that under pharmacologically induced A1 adeno-
sine receptor agonism and antagonism, only the high-
est doses of leptin effectively increased the lipolytic rate
of lean fat cells points to the possibility that the
mediation of lipolysis stimulation by leptin may only be
partial and not complete. A similar response in physi-
ological function can therefore be considered.
Thus, removal of adenosine by treatment of adipo-
cytes with ADA did not stimulate lipolysis in the obese
animal to the same extent it did in control lean rats.
However, low lipolytic rates observed in fat cells from
obese rats could be stimulated to rates observed in lean
fat cells either by treatment with A1 adenosine antago-
nist or by prior treatment with PTX, which uncouples
Gi from its receptor. If the inherent tonic activity of Gi
is pharmacologically eliminated an increase in lipolysis
can be observed, i.e., inactivating the inhibitory arm of
the signaling pathway results in a predominance of
lipolysis stimulation over inhibition. Under these ex-
perimental conditions, direct stimulation of adenylyl
cyclase by FSK, which directly activates the catalytic
component of adenylyl cyclase without receptor or Gs
involvement, produced equivalent responses in lean
and obese adipocytes.
The involvement of leptin in adenylate cyclase activ-
ity in the transmembrane adenosinergic signaling sys-
tem of adipocytes is feasible from both a genetic and
biochemical/functional point of view. The ADA gene is
among the candidate genes with evidence of linkage to
body fat (24–27). Furthermore, suppression of Gia2
expression in adipocytes of transgenic mice by means of
inducible antisense RNA reduced fat deposition (28),
suggesting the relevance of Gi proteins in mediating
the inhibitory regulation of the adenylyl cyclase in vivo.
Our findings agree with previous observations report-
ing abnormalities in the adenylyl cyclase transmem-
brane signaling system from genetically obese rodents
and humans (24, 29–38). Researchers have observed
that adenylate cyclase is less sensitive to stimulation by
b-adrenergic hormones and more sensitive to inhibi-
tion by A1 adenosine agonism in adipocyte membranes
isolated from leptin-deficient ob/ob mice relative to
membranes isolated from lean littermates (24, 29, 30).
Neither the amount of Gi nor receptor density can be
used as an explanation for the abnormally active inhib-
itory arm of the adenylyl cyclase system. Comparative
estimates of Gi and Gs in plasma membranes from
adipocytes did not support the notion that the abnor-
mal signal behavior was due to an excess of Gi (24). On
the contrary, previous reports indicate there is less Gi
relative to Gs in the obese vs. the lean Zucker mem-
branes. The receptor Gi protein complex in mem-
branes of obese animals is about fourfold more sensi-
tive to GTP than the complex from lean rats. Gia1 and
Gia2 have both been shown to be low in obese mem-
branes (24, 33). However, when those experiments
were performed no access to Gia recombinant stan-
dards was available and the exact specificity of the
antibodies was not established. More recent studies in
Zucker rats and humans using recombinant standards
indicate that it is Gia1 that responds specifically to the
obese condition and suggest that Gia1 transduces the
adenosine receptor signal (37, 38). Likewise, excess A1
adenosine receptor number in obese fat cells does not
provide the underlying mechanism for the decreased
basal lipolytic rate observed in fa/fa rats as comparable
receptor density per milligram of protein in adipocytes
from lean and fa/fa rats has been reported (24, 32).
The present study raises the possibility that the
hormonal control of lipolysis is altered in fa/fa rats
because the enhanced A1 adenosine receptor-mediated
inhibition of adenylate cyclase is not counterbalanced
by the lipolytic effect of leptin. Under physiological
circumstances, leptin could oppose the tonic inhibition
of lipolysis of adenosine. Thus, leptin may influence the
balance between lipolytic and lipogenic mechanisms,
exerting a homeostatic control on fat cells by counter-
acting the tonic inhibition of lipolysis of endogenous
adenosine. But it remains unclear to what extent tonic
inhibition by adenosine is actually curtailed by the
leptin-induced stimulation of lipolysis under patho-
physiological circumstances and whether this effect
differs among fat depots.
This is not the first study to report a functional
relation between adenosine and leptin. Cheng et al.
(39) showed that adenosine appears to be involved in
the insulin-stimulated release of leptin from isolated rat
adipocytes. Furthermore, the adenosinergic system has
been reported to increase leptin secretion by directly
activating adenosine A1 receptors in fat tissue (40).
However, the finding of an A1 adenosine receptor-Gi
signaling effect in leptin-induced lipolysis has not been
reported before. Adenosine, acting via the A1 receptor
coupled to Gi, accounts for a tonic inhibition of lipol-
ysis in rat adipocytes that cannot be counteracted in the
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leptin receptor-deficient white adipose tissue of fa/fa
rats.
The present study does not indicate whether leptin-
induced lipolysis is accompanied by increases in cAMP
or whether, like norepinephrine, leptin activates the
hormone-sensitive lipase (17). Addressing these ques-
tions may be of physiological relevance since leptin
signaling is believed to be transduced via the STAT/
JAK pathway (41) and leptin has been shown to stimu-
late a novel form of lipolysis in which glycerol is
released without a proportional release in free fatty
acids (11). The level of expression of G-proteins is
sensitive to both the nutritional and hormonal states of
the organism (24). Alterations in adenylyl cyclase activ-
ity in response to high-energy diets (42) as well as in
hypothyroidism (43–45) have been reported. Further-
more, the mechanism of action disentangled here may
be applied not only to lipid metabolism regulation, but
also to glucose homeostasis and insulin resistance. The
molecular basis for the influence of A1 adenosine
receptors on insulin signaling is not completely known,
but several instances of cross-talk between the Gi pro-
tein pathway and the insulin signal have been reported
(36, 46–49). It will be interesting to unravel the poten-
tial participation of leptin in these phenomena and
determine whether the pharmacologic manipulation of
this system might be of potential therapeutic interest
for the treatment of both obesity and insulin resistance.
In summary, these results strongly suggest that the
lipolytic effect of leptin is located at the adenylate
cyclase/Gi proteins step. The present study envisages
the possibility that leptin may function as an important
autocrine physiological regulator signal, controlling
lipolysis by opposing the adenosine A1 receptor-medi-
ated inhibition of lipolysis. An altered functional regu-
lation of lipolysis due to defective leptin-induced stim-
ulation could be a molecular mechanism causing or
maintaining an increased adipose tissue mass. Thus,
regulation of the lipolytic rate of adipocytes appears to
depend in part on the balanced effect of the stimula-
tory response attributable to leptin and the inhibitory
response attributable to adenosine. The present study
envisages, for the first time, the possibility that leptin is
involved in the control of lipolysis by opposing ade-
nosine-mediated tonic inhibition.
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